These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 311891)
1. Host immunocompetence in genitourinary cancer: relation to tumor stage and prognosis. Catalona WJ; Tarpley JL; Potvin C; Chretien PB Natl Cancer Inst Monogr; 1978 Dec; (49):105-10. PubMed ID: 311891 [TBL] [Abstract][Full Text] [Related]
2. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Catalona WJ; Tarpley JL; Potvin C; Chretien PB Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390 [TBL] [Abstract][Full Text] [Related]
3. Assays of immunocompetence in the staging and prognosis of cancer. Robinson JC Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761 [TBL] [Abstract][Full Text] [Related]
4. [The study of infiltrating lymphocytes in the tissues of bladder carcinoma]. Fujimoto Y; Hasegawa Y; Kato N; Sakai S; Kuriyama M; Kawada Y; Nishiura T; Takeuchi T; Isogai K Hinyokika Kiyo; 1983 Sep; 29(9):1037-45. PubMed ID: 6610297 [TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of lymphocyte functions in urological cancer patients. Elhilali MM; Paika KD; Brosman S; Fahey JL Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369 [TBL] [Abstract][Full Text] [Related]
6. Immunologic function in patients with carcinoma of the pancreas. Fortner JG; Kim DK; Hopkins L; Barrett MK; Pinsky CM; Day NK Surg Gynecol Obstet; 1980 Feb; 150(2):215-8. PubMed ID: 6965431 [TBL] [Abstract][Full Text] [Related]
7. [Influence of T-lymphocytes in bladder cancer on appearance and infiltration of recurrences (author's transl)]. Stöber U Urologe A; 1978 Sep; 17(5):296-302. PubMed ID: 309205 [TBL] [Abstract][Full Text] [Related]
8. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
9. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function. Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219 [TBL] [Abstract][Full Text] [Related]
10. Immunological responsiveness in patients with bladder cancer. Fahey JL; Brosman S; Dorey F Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117 [TBL] [Abstract][Full Text] [Related]
11. Some aspects of cell-mediated hypersensitivity in patients with melanoma. Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028 [TBL] [Abstract][Full Text] [Related]
12. Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer. Hoge AF; Bottomley RH; Shaw MT; Asal NR Cancer Treat Rep; 1976 Jul; 60(7):857-65. PubMed ID: 1009519 [TBL] [Abstract][Full Text] [Related]
13. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients. Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501 [TBL] [Abstract][Full Text] [Related]
14. Effect of sera of patients with genitourinary tract cancers on transformation of lymphocytes stimulated with anti-thymocyte globulin. Prager MD; Gregg DE; Walter MC Natl Cancer Inst Monogr; 1978 Dec; (49):127-30. PubMed ID: 311892 [TBL] [Abstract][Full Text] [Related]
15. [Controlled study of unspecific cellular immunity in cancer patients]. Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the immunologic competence in patients with urogenital cancers. I. Evaluation of nonspecific cellular immunity by delayed cutaneous hypersensitivity test and lymphocytes blastoid formation (author's transl)]. Ono H Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1064-77. PubMed ID: 7198700 [No Abstract] [Full Text] [Related]
17. [Prognostic significance of immunologic tests in cancer of the oral cavity]. Szpirglas H; Castet-Sardjveladzé E; Piadé R; Roth-Ghanassia V; Tsamis J Rev Stomatol Chir Maxillofac; 1977; 78(3):207-18. PubMed ID: 329403 [TBL] [Abstract][Full Text] [Related]
18. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients. Aziz M; Das TK; Rattan A Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases]. Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of host immunocompetence in urologic cancer patients. Catalona WJ; Smolev JK; Harty JI J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]